SRTS (Sensus Healthcare) Tariff Resilience Score: 6/10 (As of Jul. 02, 2026)


SRTS Sensus Healthcare Inc SRTS
74 GF Score
Price $3.05
GF Value $2.85
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Sensus Healthcare Tariff Resilience Score?

Sensus Healthcare SRTS +0.33% 74 Tariff Resilience Score is 6 as of Jul. 02, 2026. GuruFocus rates SRTS with a GF Score™ of 74/100 and a GF Value™ of $2.85 (Fairly Valued). The stock has 4 warning signs investors should review. Among 838 Medical Devices & Instruments companies, Sensus Healthcare ranks better than 91.05% on this metric.

Sensus Healthcare has the Tariff Resilience Score of 6, which implies that the company might have Average Resilient.

Sensus Healthcare has Sensus Healthcare Inc has moderate tariff exposure due to its international supply chain for medical devices. The company has some pricing power and alternative suppliers, but past tariffs have impacted costs. Industry-specific exemptions provide some relief.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Sensus Healthcare might have Average Resilient.

Sensus Healthcare  (NAS:SRTS) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Sensus Healthcare Tariff Resilience Score Related Terms

SRTS vs COCH, QTI, MDAI: Tariff Resilience Score Comparison

For the Medical Devices subindustry, Sensus Healthcare's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sensus Healthcare Tariff Resilience Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sensus Healthcare's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Sensus Healthcare's Tariff Resilience Score falls into.


SRTS
74GF Score
Sensus Healthcare Inc SRTS
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 6 mean?
Sensus Healthcare (SRTS) has a Tariff Resilience Score of 6 as of Jul. 02, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Sensus Healthcare ranks #75 out of 838 companies in the Medical Devices & Instruments industry, placing it in the top 8.9%.
Is Sensus Healthcare's Tariff Resilience Score too high?
Sensus Healthcare's current Tariff Resilience Score is 6. Based on the distribution chart, Sensus Healthcare ranks #75 out of 838 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Sensus Healthcare has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sensus Healthcare's Tariff Resilience Score compare to COCH and QTI?
According to the Medical Devices & Instruments industry distribution chart, Sensus Healthcare ranks #75 out of 838 companies for Tariff Resilience Score. This places Sensus Healthcare in the top 9% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Devices & Instruments company?
A good Tariff Resilience Score depends on the Medical Devices & Instruments industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Sensus Healthcare's current Tariff Resilience Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sensus Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Sensus Healthcare (SRTS) is currently considered Fairly Valued. The stock's GF Value™ is $2.85, compared to a current price of $3.05 — trading 6.8% above its estimated fair value. The current Tariff Resilience Score is 6. Sensus Healthcare's overall GF Score™ is 74/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Sensus Healthcare (SRTS), the current Tariff Resilience Score is 6 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sensus Healthcare (SRTS) Overvalued in 2026?

Based on GuruFocus' analysis, Sensus Healthcare stock appears to be overvalued. The current stock price of $3.05 is trading 6.8% above its estimated GF Value™ of $2.85. GuruFocus considers Sensus Healthcare to be Fairly Valued.

Key valuation signals for SRTS:

  • Tariff Resilience Score: 6
  • GF Value™: $2.85 vs. price of $3.05 (6.8% above fair value)
  • GF Score™: 74/100 with 4 warning signs

No single metric tells the full story. See the SRTS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sensus Healthcare Business Description

Other Exchanges 5TX:Germany
Address 851 Broken Sound Parkway, NW, Suite 215, Boca Raton, FL, USA, 33487
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
74GF Score

Get the complete analysis for SRTS

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.05
Price
$2.85
GF Value